// App-Quantinova.ai

37 EP428 : Lixisenatide clinical experience on patients with type 2 diabetes and obesity in Endocrinology Offices

Researchers

Presenter

  • Maria Teresa Muros de Fuentes

Principal Investigators

  • Gonzalo Piedrola-Maroto

  • Mercedes Vazquez-Gutierrez

  • Isabel Mancha-Doblas

  • Miguel Quesada-Charneco

  • Silvia Maraver-Selfa

  • M Jose Tapia-Guerrero

  • Daniel Cepero-Garcia

  • Rosa Orduna-Espinosa

  • Joaquin Pechuan-Asensio

  • Elena Ferrandiz-Millon

  • Purificacion Galera-Martinez

Medical Centers

  • Department of Endocrinology, Virgen de la Victoria and Regional Hospitals, Malaga, Spain

  • Department of Endocrinology, Virgen de las Nieves Hospital, Granada, Spain

  • Endocrinology Private Office, Granada, Spain

  • Department of Endocrinology, Torrecardenas Hospital, Almeria, Spain

  • Department of Endocrinology, San Cecilio Hospital, Granada, Spain

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

Disease

  • Type 2 diabetes mellitus

  • Hypertension

  • Diabetes

  • Obesity

Biomarkers

  • GC Vitamin D Binding Protein

  • Hemoglobin A1c

  • Sex hormone binding globulin

  • Body mass index

Drug/Treatment

  • Lixisenatide

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved